Tag Archives: First

Charity launches first dedicated helpline for people who struggle to sleep

A charity has launched the UK’s first dedicated helpline for people who struggle to sleep. The average UK adult suffers nine bad nights’ sleep per month – equating to around 500 million across the country each month, but there is limited support. To combat the problem, The Sleep Charity has teamed up with high street… Read More »

9/11 First Responders Face Higher Cancer Risk 20 Years Later

By Amy Norton HealthDay Reporter MONDAY, Sept. 13, 2021 (HealthDay News) — Twenty years on, responders to the World Trade Center attacks in New York City are showing increased risks of certain cancers, two new studies confirm. Researchers found higher-than-average rates of prostate cancer among firefighters, medics and other workers who toiled at the disaster… Read More »

Texas’ hospital system confirms its first case of new COVID-19 lambda variant

Loading the player… Just when people were beginning to wrap their heads around the delta variant of COVID-19, this week, Texas’ hospital system has become the first to report a case of the lambda variant. According to ABC News, Monday, Houston Methodist Hospital, which operates eight hospitals in its network, confirmed its first case of the… Read More »

Garima Arora: Exceptionally Talented First Indian Female Michelin star Chef Talks about her success story

Garima Arora is the Chef and Owner of Restaurant Gaa and the all-day modern Indian eatery & bar, HERE, in Bangkok. Her cuisine is focused on applying traditional Indian cooking techniques onto locally sourced ingredients. In 2018, Arora became the first Indian female chef to earn a Michelin star at the age of 32. In… Read More »

FDA Approves Trodelvy, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The… Read More »